Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Time of Treatment With Low Molecular Weight Heparins in Cancer Patients With Thromboembolic Disease. Procoagulant Role of Phospholipid-dependent Microparticles.

NCT03134820 is registered in ClinicalTrials.gov with Delos Clinical as lead sponsor.

NCT NCT03134820
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03134820 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Time of Treatment With Low Molecular Weight Heparins in Cancer Patients With Thromboembolic Disease. Procoagulant Role of Phospholipid-dependent Microparticles.
Lead sponsor
Delos Clinical
Phase
Observational
Overall status
Completed
Start date
December 15, 2015
Completion date
March 31, 2017
Enrollment
352 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, pulmonary thromboembolisms, venous thromboembolism